Farmacosmo S.p.A. (BIT:COSMO)
Italy · Delayed Price · Currency is EUR 0.4870
+0.0070 (1.46%)
At close: Sep 4, 2026
Farmacosmo Balance Sheet
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Assets
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 0.95 | 3.12 | 5.07 | 6.85 | 1.41 |
Cash & Short-Term Investments | 0.95 | 3.12 | 5.07 | 6.85 | 1.41 |
Cash Growth | -69.67% | -38.37% | -26.06% | 385.48% | -31.44% |
Accounts Receivable | 1.58 | 3.7 | 4.95 | 5.26 | 4.81 |
Other Receivables | 7.57 | 1.07 | 1.86 | 4.88 | 0.87 |
Receivables | 9.15 | 4.77 | 6.82 | 10.14 | 5.68 |
Inventory | 4.87 | 9.26 | 7.33 | 4.73 | 2.08 |
Prepaid Expenses | - | - | - | 0.17 | - |
Other Current Assets | - | -0 | - | - | - |
Total Current Assets | 15.69 | 17.95 | 19.96 | 21.89 | 9.17 |
Property, Plant & Equipment | 0.23 | 0.29 | 0.49 | 0.48 | 0.3 |
Long-Term Investments | 0.15 | 0.05 | 0.05 | 0.05 | 0.06 |
Goodwill | 8.77 | 8.28 | 10.85 | 11.18 | 0 |
Other Intangible Assets | 1.05 | 2.93 | 2.87 | 2.32 | 0.59 |
Long-Term Accounts Receivable | - | - | - | 0.05 | - |
Long-Term Deferred Charges | 1.95 | 1.19 | 1.95 | 2.78 | 0.51 |
Other Long-Term Assets | 0.24 | 0.18 | 0.23 | 0.47 | 0.14 |
Total Assets | 28.08 | 30.87 | 36.4 | 39.24 | 10.77 |
Liabilities
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 10.03 | 10.24 | 11.91 | 14.5 | 8.01 |
Accrued Expenses | 0.36 | 0.34 | 0.2 | 0.16 | 0.03 |
Short-Term Debt | 0.3 | - | - | - | - |
Current Portion of Long-Term Debt | 5.83 | 6.65 | 5.19 | 0.69 | 0.24 |
Current Income Taxes Payable | 0.25 | 0.38 | 0.32 | 0.41 | 0.39 |
Other Current Liabilities | 3.29 | 0.73 | 0.78 | 2.19 | 0.16 |
Total Current Liabilities | 20.06 | 18.34 | 18.41 | 17.96 | 8.83 |
Long-Term Debt | 1.43 | 0.68 | 1.5 | 1.18 | 0.38 |
Long-Term Unearned Revenue | 0.12 | 0.24 | 0.38 | 0.53 | 0.18 |
Long-Term Deferred Tax Liabilities | 0.62 | 0.01 | 0.03 | 0.03 | - |
Other Long-Term Liabilities | 0.56 | 0.77 | 0.7 | 0.54 | 0.42 |
Total Liabilities | 22.79 | 20.03 | 21.03 | 20.22 | 9.8 |
Shareholders' Equity
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 3.48 | 3.48 | 3.48 | 3.01 | 0.07 |
Additional Paid-In Capital | 13.79 | 13.79 | 13.79 | 14.26 | - |
Retained Earnings | -11.71 | -6.58 | -4.25 | 0.38 | 0.9 |
Treasury Stock | -0.11 | -0.11 | -0.11 | -0.25 | - |
Comprehensive Income & Other | -0 | -0 | -0 | - | - |
Total Common Equity | 5.45 | 10.58 | 12.91 | 17.4 | 0.97 |
Minority Interest | -0.16 | 0.25 | 2.46 | 1.62 | - |
Shareholders' Equity | 5.29 | 10.84 | 15.37 | 19.02 | 0.97 |
Total Liabilities & Equity | 28.08 | 30.87 | 36.4 | 39.24 | 10.77 |
Additional Metrics
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 7.55 | 7.33 | 6.69 | 1.87 | 0.62 |
Net Cash (Debt) | -6.61 | -4.21 | -1.63 | 4.98 | 0.79 |
Net Cash Growth | - | - | - | 530.10% | -59.56% |
Net Cash Per Share | -0.17 | -0.11 | -0.04 | - | 0.03 |
Filing Date Shares Outstanding | 38.81 | 38.81 | 38.81 | - | 30 |
Total Common Shares Outstanding | 38.81 | 38.81 | 38.81 | - | 30 |
Working Capital | -4.37 | -0.39 | 1.55 | 3.94 | 0.35 |
Book Value Per Share | 0.14 | 0.27 | 0.33 | - | 0.03 |
Tangible Book Value | -4.36 | -0.62 | -0.81 | 3.89 | 0.38 |
Tangible Book Value Per Share | -0.11 | -0.02 | -0.02 | - | 0.01 |
Land | 0.14 | 0.14 | 0.14 | - | 0.14 |
Machinery | 0.4 | 0.44 | 0.56 | - | 0.28 |